Skip to main content
Top
Published in: BMC Gastroenterology 1/2015

Open Access 01-12-2015 | Research article

Identifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus: a cross-sectional study with pair-matched controls

Authors: Yi Shen, Jian Zhang, Hui Cai, Jian-Guo Shao, You-Yi Zhang, Yan-Mei Liu, Gang Qin, Yan Qin

Published in: BMC Gastroenterology | Issue 1/2015

Login to get access

Abstract

Background

The presence of diabetes mellitus (DM) is associated with increased liver morbidity and mortality risk in patients with chronic hepatitis B (CHB). Aim of this study was to identify factors associated with type 2 diabetes mellitus (T2DM) in CHB patients.

Methods

A cross-sectional study with pair-matched controls was conducted in Nantong Third People’s Hospital, Nantong University, China. From January 2008 to December 2012, a total of 1783 CHB patients were screened for study subjects, among whom 207 patients with T2DM were enrolled as cases and 207 sex- and age-matched non-DM patients as controls. Demographic, anthropometric, lifestyle, clinical, and laboratory data were obtained from each subject.

Results

In the univariate model, thirteen variables showed marked differences between the DM group and non-DM group. Patients with longer duration of CHB (≥15 years) and alcoholic steatosis showed the highest likelihood of T2DM (odds ratio = 5.39 and 4.95; 95% confidence intervals 2.76-10.53 and 1.65-14.91). In the multivariate adjusted analysis, three CHB-related factors, namely high viral load, long duration of illness, and presence of cirrhosis, contributed to substantially increase the likelihood of T2DM, in addition to the other five risk factors including family history of DM, low education level, elevated triglycerides (TG), gamma-glutamyl transferase (GGT) levels, and presence of alcoholic steatosis.

Conclusions

Our findings suggest that high viral load, long duration of CHB, presence of cirrhosis, alcoholic steatosis and several other factors may be potential risk factors for development of T2DM in CHB patients. It is of vital importance to monitor glucose in high-risk CHB patients and aggressively intervene on modifiable risk factors.
Literature
1.
go back to reference Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J (Engl). 2009;122(1):3–4. Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J (Engl). 2009;122(1):3–4.
3.
go back to reference Hsiang JC, Gane EJ, Bai WW, Gerred SJ. Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients. J Gastroenterol Hepatol. 2015;30:591–9.PubMedCrossRef Hsiang JC, Gane EJ, Bai WW, Gerred SJ. Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients. J Gastroenterol Hepatol. 2015;30:591–9.PubMedCrossRef
4.
go back to reference Li Q, Li WW, Yang X, Fan WB, Yu JH, Xie SS, et al. Type 2 diabetes and hepatocellular carcinoma: a case–control study in patients with chronic hepatitis B. Int J Cancer. 2012;131(5):1197–202.PubMedCrossRef Li Q, Li WW, Yang X, Fan WB, Yu JH, Xie SS, et al. Type 2 diabetes and hepatocellular carcinoma: a case–control study in patients with chronic hepatitis B. Int J Cancer. 2012;131(5):1197–202.PubMedCrossRef
5.
go back to reference Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;43(6):1295–302.PubMedCrossRef Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;43(6):1295–302.PubMedCrossRef
6.
go back to reference Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology. 2008;135(1):111–21.PubMedCrossRef Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology. 2008;135(1):111–21.PubMedCrossRef
7.
go back to reference Li-Ng M, Tropp S, Danoff A, Bini E. Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Dig Liver Dis. 2007;39(6):549–56.PubMedCrossRef Li-Ng M, Tropp S, Danoff A, Bini E. Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Dig Liver Dis. 2007;39(6):549–56.PubMedCrossRef
8.
go back to reference Huang ZS, Huang TS, Wu TH, Chen MF, Hsu CS, Kao JH. Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: a ten‐year observation. J Gastroenterol Hepatol. 2010;25(8):1420–5.PubMedCrossRef Huang ZS, Huang TS, Wu TH, Chen MF, Hsu CS, Kao JH. Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: a ten‐year observation. J Gastroenterol Hepatol. 2010;25(8):1420–5.PubMedCrossRef
10.
go back to reference American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29 Suppl 1:S43–8. American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29 Suppl 1:S43–8.
11.
go back to reference Ji L-N, Lu J-M, Weng J-P, Jia W-P, Zhou Z-G, Zou D-J. China guideline for type 2 diabetes. Chin J Diabetes. 2012;20(1):s1–36. Ji L-N, Lu J-M, Weng J-P, Jia W-P, Zhou Z-G, Zou D-J. China guideline for type 2 diabetes. Chin J Diabetes. 2012;20(1):s1–36.
12.
go back to reference O'Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver D, Practice Parameters Committee of the American College of G. Alcoholic liver disease. Hepatology. 2010;51(1):307–28.PubMedCrossRef O'Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver D, Practice Parameters Committee of the American College of G. Alcoholic liver disease. Hepatology. 2010;51(1):307–28.PubMedCrossRef
13.
go back to reference Qin G, Shao JG, Wang B, Shen Y, Zheng J, Liu XJ, et al. Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience. Medicine. 2014;93(28):e338.PubMedPubMedCentralCrossRef Qin G, Shao JG, Wang B, Shen Y, Zheng J, Liu XJ, et al. Artificial liver support system improves short- and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure: a single-center experience. Medicine. 2014;93(28):e338.PubMedPubMedCentralCrossRef
14.
go back to reference Postic C, Dentin R, Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab. 2004;30(5):398–408.PubMedCrossRef Postic C, Dentin R, Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab. 2004;30(5):398–408.PubMedCrossRef
15.
go back to reference Alavian SM, Hajarizadeh B, Nematizadeh F, Larijani B. Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease. BMC Endocr Disord. 2004;4(1):4.PubMedPubMedCentralCrossRef Alavian SM, Hajarizadeh B, Nematizadeh F, Larijani B. Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease. BMC Endocr Disord. 2004;4(1):4.PubMedPubMedCentralCrossRef
16.
go back to reference Picardi A, D'Avola D, Gentilucci UV, Galati G, Fiori E, Spataro S, et al. Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes Metab Res Rev. 2006;22(4):274–83.PubMedCrossRef Picardi A, D'Avola D, Gentilucci UV, Galati G, Fiori E, Spataro S, et al. Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes Metab Res Rev. 2006;22(4):274–83.PubMedCrossRef
17.
go back to reference Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care. 2007;30(3):734–43.PubMedCrossRef Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care. 2007;30(3):734–43.PubMedCrossRef
18.
go back to reference Wang C-S, Wang S-T, Yao W-J, Chang T-T, Chou P. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Am J Epidemiol. 2007;166(2):196–203.PubMedCrossRef Wang C-S, Wang S-T, Yao W-J, Chang T-T, Chou P. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Am J Epidemiol. 2007;166(2):196–203.PubMedCrossRef
19.
go back to reference Thuluvath PJ, John PR. Association between hepatitis C, diabetes mellitus, and race. a case–control study. Am J Gastroenterol. 2003;98(2):438–41.PubMed Thuluvath PJ, John PR. Association between hepatitis C, diabetes mellitus, and race. a case–control study. Am J Gastroenterol. 2003;98(2):438–41.PubMed
20.
go back to reference Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol. 2008;23(5):779–82.PubMedCrossRef Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol. 2008;23(5):779–82.PubMedCrossRef
21.
go back to reference Lee JG, Lee S, Kim YJ, Cho BM, Park JS, Kim HH, et al. Association of chronic viral hepatitis B with insulin resistance. World J Gastroenterol. 2012;18(42):6120–6.PubMedPubMedCentralCrossRef Lee JG, Lee S, Kim YJ, Cho BM, Park JS, Kim HH, et al. Association of chronic viral hepatitis B with insulin resistance. World J Gastroenterol. 2012;18(42):6120–6.PubMedPubMedCentralCrossRef
22.
go back to reference Tkachenko LI, Maleev VV. Clinical features of chronic hepatitis B in the presence of metabolic syndrome and insulin resistance. Ter Arkh. 2014;86(8):18–22.PubMed Tkachenko LI, Maleev VV. Clinical features of chronic hepatitis B in the presence of metabolic syndrome and insulin resistance. Ter Arkh. 2014;86(8):18–22.PubMed
23.
go back to reference Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–101.PubMedCrossRef Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–101.PubMedCrossRef
24.
go back to reference Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, Tanizaki Y, et al. Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study. Obesity. 2007;15(7):1841–50.PubMedCrossRef Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, Tanizaki Y, et al. Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study. Obesity. 2007;15(7):1841–50.PubMedCrossRef
25.
go back to reference Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol. 2011;26(9):1361–7.PubMed Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol. 2011;26(9):1361–7.PubMed
26.
go back to reference Balkau B, Lange C, Vol S, Fumeron F, Bonnet F, Group Study DESIR. Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol. 2010;10:56.PubMedPubMedCentralCrossRef Balkau B, Lange C, Vol S, Fumeron F, Bonnet F, Group Study DESIR. Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol. 2010;10:56.PubMedPubMedCentralCrossRef
Metadata
Title
Identifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus: a cross-sectional study with pair-matched controls
Authors
Yi Shen
Jian Zhang
Hui Cai
Jian-Guo Shao
You-Yi Zhang
Yan-Mei Liu
Gang Qin
Yan Qin
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2015
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-015-0263-9

Other articles of this Issue 1/2015

BMC Gastroenterology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine